Some derivatives of bactobolin were prepared from bactobolin (1) by transformation of the dichloromethyl group at C-3 to the hydroxymethyl, carboxylic acid, methanesulfonyloxymethyl and aldehydeoxime groups. The derivatives proved to be less active than the parent antibiotic 1 against bacteria as well as cytotoxicity, indicating that the functionality at C-3 considerably influences the biological activity.
Some derivatives of bactobolin were prepared from bactobolin (1) by transformation of the dichloromethyl group at C-3 to the hydroxymethyl, carboxylic acid, methanesulfonyloxymethyl and aldehydeoxime groups. The derivatives proved to be less active than the parent antibiotic 1 against bacteria as well as cytotoxicity, indicating that the functionality at C-3 considerably influences the biological activity.
Bactobolin (1) produced by Pseudomonas sp. BMG13-A71) is of biological interest since it possesses potent antimicrobial and antitumor activities1-5), suppressing effect on antibody production6) and therapeutic effect on autoimmune encephalomyelitis7). However, the undesirable toxicities1) have limited its pharmaceutical applications.
The promising biological activity and the unique chemical structure of 1 have attracted interest in the total synthesis of 18,9) and the new active analogues10-12), Until now, structural modification of 1 have been done in the side chain of amino acid10,11) and the hydroxy groups of the skelton12).
On the other hand, actinobolin (8)13) from culture filtrate of Streptomyces griseoviridus var. atrofaciens is structurally identical to 1 except for the functionality at C-3. In spite of close structural similarity, the two antibiotics differ considerably in their biological activity and toxicity, 8 being less active than 1. These facts suggest that the functionality at C-3 plays an important role on the biological activities.
In the course of our study of the structure-activity relationship of 1 and 8, chloromethyl and dimethyl derivatives of 1 (2 and 3)14) and 3-epi-actinobolin (9)15 ( Fig. 1 ) were proved to be less active than 1 against bacteria as well as cytotoxicity. These results prompted us to examine the effect of further modifying functionality at C-3 on biological activity. We here report the synthesis and biological activities of hydroxymethyl, carboxylic acid, methanesulfonyloxymethyl and aldehydeoxime derivtives of bactobolin (4, 5, 6 and 7, respectively) for studying an role of a sterically bulky and electronegative chlorine atom at C-9 in the biological activity of 1.
Synthesis
The synthetic route of bactobolin derivatives is outlined in scheme 1. The syntheses of bactobolin derivatives are began with the chloride 10 prepared from bactobolin (1) by our method14). Transformation of the chloromethyl group at C-3 has been proved to be quite difficult. After several unsuccessful attempts to substitute chlorine atom of chloromethyl group of 10, we found that the chloride 10 was hydrolyzed in displacement with cyanide using hypervalent cyanosilicate derivatives16), generated in situ by reaction of trimethylsilyl cyanide (TMSCN) with tetrabutylammonium fluoride (TBAF). respectively, in 1H NMR spectrum (CH3OD), indicative of syn and anti isomeric mixture of 7 in a ratio of 7 to 1.
Biological Activities
Compounds 4, 5, 6 and 7 show less inhibitory activity than 1 against several microorganisms (Table 1) and cytotoxicity (Table 2) . Especially, the carboxylic acid 5 loses antibacterial activity as well as cytotoxicity. Unexpectedly, electronegativity and sterically bulkiness of the functional groups at C-3 in this study are proved to be little effective for biological activity. These results indicate that the functionality at C-3 participates critically in the biological activity and that chlorinated functional group enhances the inhibitory activity against bacteria and the cytotoxicity. Table 1 . Antibacterial activities of bactobolin (1) and it's derivatives (4, 5, 6, 7). 3-Carboxy-3-dedichloromethyl-N-(p-methoxybenzyloxycarbonyl)bactobolin (15) To the mixture of CrO3 (306mg, 3.07mmol) and was added a solution of 13 (189mg, 0.279mmol) in dichloromethane (6ml), and the reaction mixture was stirred at room temperature for 1 hour. After filtration, the filtrate was evaporated to give an oil, which was dissolved in a mixture of t-butanol (4ml) and water (1.4ml). To the NaClO2 (85.7mg, 0.948mmol), and the reaction mixture was stirred at room temperature for 3 hours. After being the solvent gave an oil, which was subjected to flash column chromatography on silica gel. Elution with CHCl3-MeOH (3:1) gave an oil. The oil was dissolved in 70% acetic acid (1ml), and the solution was stirred at room temperature for 1 hour. Evaporation of the solvent gave an oil, which was subjected to preparative TLC on silica gel developed with chloroform-methanol 3-Carboxy-3-dedichloromethylbactobolin (5) Procedure used for the preparation of 5 from 15 was similar to those used for the preparation of 4 from 11; the 1.49 (3H, s, 10-CH3), 2.29 (1H, ddd, J=2.6, 9.6 and 18.7
Hz, 7-Hax), 2.70 (1H, d with small coupling, J=9.6Hz, 4a-H), 2.76 (1H, dd, J=7.1 and 18.7Hz, 7-Heq), 3.06 (1H, t, J=9.6Hz, 5-H), 3.74 (1H, dt, J=7.1, 9.6 and 9.6Hz, 6-H), 3.81 (1H, q, J=6.9Hz, 12-H); MS (FAB negative) m/z 343
To a solution of 12 (11mg, 0.021mmol) in mmol) at room temperature, and the reaction mixture was stirred at room temperature overnight. Evaporation of the solvent gave an oil, which was dissolved in ethyl acetate.
The solution was washed with water, dried over MgSO4, and filtered. Evaporation of the filtrate gave an oil, which was subjected to preparative TLC on silica gel developed with toluene-acetone 3-Dedichloromethyl-3-methanesulfonyloxymethyl-N-(pmethoxybenzyloxycarbonyl)bactobolin (17) A solution of 16 (10mg, 0.016mmol) in 80% aqueous acetic acid (0.5ml) was stirred at room temperature overnight. Evaporation of the solvent gave an oil, which was subjected to preparative TLC on silica gel developed with toluene-acetone 
A solution of 18 (14.8mg, 0.027mmol) in a mixture of methanol (0.5ml) and 10% hydrogen chloride in methanol (0.5ml) was stirred with 10% palladium on carbon (14mg) under atmosphere of hydrogen for 2 hours. After filtration, evaporation of the filtrate gave an oil, which was subjected to preparative TLC on silica gel developed with ethyl acetate-methanol (3:1) to give 7 as a colorless foam (7.0 (3H, d, J=6.9Hz, 13-CH3 (anti)), 1.30 (3H, d, J=6.8Hz, 13-CH3 (syn)), 1.46 (3H, s, 10-CH3 (syn)), 1.60 (3H, s, 10-CH3 (anti)), 2.37 (1H, ddd, J=2.7, 9.7 and 18.6Hz, 7-Hax (syn)), 2.30-2.40 (1H, overlapped with 7-Hax (syn), 7-Hax (anti)), 2.65-2.85 (2H, m, 7-Heq (syn)+4a-H (syn)), 2.78-2.87 (1H, overlapped with 7-Heq (syn), 7-Heq (anti)), 2.93 (1H, d with small coupling, J=9.3Hz, 4a-H (anti)), 3.18 (1H, t, J=9.7Hz, 5-H (syn)), 3.27-3.35 (1H, overlapped with solvent, 5-H (anti)), 3.50 (1H, q, J=6.9 Hz, 12-CH (anti)), 3.57 (1H, q, J=6.8Hz, 12-CH (syn)), 3 .73 (1H, dt, J=7.3, 9.7 and 9.7Hz, 6-H (syn)), 3.83 (1H, dt, J=6.8, 9.6 and 9.6Hz, 6-H (anti)), 4 
